| 000 | 00939 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517154735.0 | ||
| 264 | 0 | _c20180423 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a2213-8595 | ||
| 024 | 7 |
_a10.1016/S2213-8587(17)30178-X _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCompston, Juliet | |
| 245 | 0 | 0 |
_aSafety of long-term denosumab therapy for osteoporosis. _h[electronic resource] |
| 260 |
_bThe lancet. Diabetes & endocrinology _c07 2017 |
||
| 300 |
_a485-487 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aBone Density |
| 650 | 0 | 4 | _aBone Density Conservation Agents |
| 650 | 0 | 4 | _aDenosumab |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aOsteoporosis |
| 650 | 0 | 4 | _aOsteoporosis, Postmenopausal |
| 773 | 0 |
_tThe lancet. Diabetes & endocrinology _gvol. 5 _gno. 7 _gp. 485-487 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S2213-8587(17)30178-X _zAvailable from publisher's website |
| 999 |
_c27211644 _d27211644 |
||